• STUDY

    Care for cancer patients undergoing chemotherapy

 

ConnectedLife partners with National Cancer Centre of Singapore in a study to help patients in the management of symptoms arising from cancer treatment.

 

A study to explore the feasibility and acceptability of a monitoring service for patients undergoing chemotherapy using the SpecialistCare platform. This facilitates the scheduling and delivery of medication reminders to coincide with a chemotherapy regimen set by a pharmacist and the oncology care team.

 

Chemotherapy induced nausea and vomiting (CINV) is also assessed through a specially designed interactive clockface on a smartwatch, with associated alerts that are generated and delivered to the care team if a patient is in need of additional care.
Designated electronic clinical outcome assessments are also delivered to patients remotely through the SpecialistCare app. 

For more information, please contact us.

Recent Posts

Pharmaceutical SOE Holding Signs MoU with Four Global Companies at G20 SoE Conference 2022

(Nusa Dua 18/10) Holding SOE Pharmaceutical Bio Farma, carried out four signing of cooperation with four global Healthcare Companies on the...

Apollo Hospitals integrates Cardiovascular Risk Tool with ConnectedLife digital wellness solutions

Apollo Hospitals has collaborated with ConnectedLife, leaders in the application of motor state diagnostics, to integrate Apollo’s AICVD tool with ConnectedLife’s...

Hey there, I’m a cool multi-purpose modal.
Use me for almost anything!


Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries.